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ABSTRACT
Background and the purpose of the study: Aging is the major risk factor for neurodegenerative 
diseases and oxidative stress is involved in the pathophysiology of them. Oxidative stress can 
induce neuronal damages and modulate intracellular signaling, ultimately leading to neuronal 
death by apoptosis or necrosis. In this study, the possible antioxidant and neuroprotective 
properties of the natural polyphenolic antioxidant compound, curcumin against homocysteine 
(Hcy) neurotoxicity was investigated.
Methods: Curcumin (5, 15, 45 mg/kg) was injected intraperitonealy (i.p.) once daily for a period 
of 10 days beginning 5 days prior to Hcy (0.2 µmol/µl)  intracerebroventricular (i.c.v)  injection 
in rats. Biochemical and behavioral studies, including passive avoidance learning and locomotor 
activity tests were studied 24 hrs after the last curcumin or its vehicle injection. The cell density 
of hippocampus layers and apoptosis in rats’ hippocampi by immunohistochical methods were 
also studied. 
Results  and  major  conclusion:  Results  indicated  that  Hcy  could  induce  lipid  peroxidation 
and increase Malondialdehyde (MDA) and Super Oxide Anion (SOA) levels in rat’s brain.
Additionally, Hcy impaired memory retention in passive avoidance learning test. However, 
curcumin decreased MDA and SOA levels significantly and improved learning and memory in 
rats. On the other hand Hcy could induce cell death and apoptosis in rats’ hippocampi which 
was inhibited by curcumin. These results suggest that Hcy may induce lipid peroxidation in 
rat’s brain. and polyphenol treatment (curcumin) improves learning and memory deficits by 
protecting the nervous system against Oxidative stress. 
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INTRODUCTION
Homocysteine (Hcy); a sulfur containing amino acid 
derived  from  the  metabolism  of  methionine,  is  an 
independent risk factor for cardiovascular disease (1). 
The thiol group of Hcy is readily oxidized in plasma and 
culture medium, resulting in the generation of reactive 
oxygen species (ROS). Moreover, Hcy has the ability 
to inhibit the expression of antioxidant enzymes such 
as glutathione peroxidase (GSH-Px), and superoxide 
dismutase (SOD) (2, 3). Hcy is an excitatory amino 
acid,  which  markedly  enhances  the  vulnerability  of 
neuronal cells to excitotoxic and oxidative injury (2). 
An elevated plasma level of Hcy (more than 14 μM) 
is termed Hyperhomocysteinemia (HHCY) (4). Hcy is 
recognized as an independent risk factor for myocardial 
infarction,  coronary  artery  disease,  strokes,  genetic 
disorders, Alzheimer’s diseases (AD) and cognitive 
impairment (5). Recently, it has been suggested that 
chronic administration of Hcy to rats affected both 
long- and short-term memory in the Morris water 
maze task (6). Additionally, in another study it was 
found that in AD patients, high Hcy plasma levels 
favored neurodegeneration (7). 
Polyphenols are natural substances that are present 
in plants, fruits and vegetables including olive oil, 
red wine and tea (8). The yellow pigment extracted 
from  the  rhizome  of  Curcuma  longa,  “curcumin” 
a  polyphenolic  non-flavonon  compound  is  the 
pharmacologically  active  substance  of  turmeric 
(9).  Curcumin  is  nontoxic  and  has  antioxidant, 
anti-inflammatory  and  anti-proliferative  activities. 
Curcumin shows antioxidant activity equivalent to 
vitamins C and E (10). Many studies have shown 
that  curcumin  is  a  potent  scavenger  of  reactive 
oxygen species, which cause oxidative damage; and 
improves  learning  and  memory  (11).  Studies  of 
animal models have shown that curcumin inhibits 
lipid  peroxidation  and  protects  kidney  cells, 
128(0.2 μmol/μl) (i.c.v) and the vehicle of curcumin (ethyl 
oleate) were injected (i.p.) for 10 days beginning 5 days 
prior to Hcy injection. In curcumin groups, curcumin 
(5, 15 and 45 mg/kg) was injected (i.p.) once daily 
for a period of 10 days beginning 5 days prior to Hcy 
(0.2 μmol/μl) i.c.v injection in rats. Biochemical and 
behavioral analyses were performed 24 hrs after the last 
injection of curcumin or its vehicle in the experimental 
groups.
Intracerebroventricular injection 
The rats were anaesthetized with ketamin/xylosin 
(10 mg/kg) and placed in a stereotaxic frame. The rat 
skull was orientated according to Paxinos and Watson 
stereotaxic  atlas  (17).  After  a  sagittal  incision,  the 
bregma suture was located and holes were drilled with 
an electrical drill at the following co-ordinates; 0.8 mm 
posterior to bregma, 1.5 mm lateral to the sagittal suture 
and 3.7 mm ventral. Care was taken not to damage 
the meninges. A Hamilton syringe with a cannula of 
diameter of 0.3 mm was used to inject 1μl of solutions 
of Hcy (0.05, 0.1, 0.2, 0.4 M) or vehicle (PBS). The 
injection was carried out in the brain ventricle at a 
rate of 1μl per 2 minutes. The cannula was left in situ 
for a further 5 min following Hcy injection to allow 
passive diffusion from the cannula tip and to minimize 
spread into the injection tract. The cannula was then 
slowly removed from the scalp, which was then closed 
with sutures. Five days after Hcy injection, rats were 
sacrificed by neck fracture and decapitated. The brain 
was removed carefully, inserted in PBS solution (0.1M) 
immediately and stored at -70° C for use in biochemical 
analysis. At the end of the study, 1µl of methylene blue 
solution (1%) was injected (i.c.v), to verify the site of 
injection (Figure 5).  
Biochemical analysis of the brain homogenate
On  the  day  of  experiment,  rat  brain  was  weighed 
(estimate  1.5  g),  and  homogenized  (10%  w/v) 
in  0.1  M  PBS  with  Polytron  homogenizer  at  pH 
of  7.4.  Homogenates  were  used  immediately  for 
detection of the biomarkers for lipid peroxidation, 
malondialdehyde  (MDA)  and  superoxide  anion 
(SOA). Lipid peroxidation was determined according to 
the modified method (18).Whole Brain homogenates (1 
ml) were incubated at 37°C in an oscillating water bath 
for one hour. At the end of the incubation period, 0.5 ml 
of BHT (0.5 mg/ml in absolute ethanol) and 1 ml of TCA 
(25%) were added. The tubes were sealed and heated 
for 10 minutes in a boiling water bath to release MDA 
(the end product of lipid peroxidation) from proteins. 
To avoid adsorption of MDA to insoluble proteins, the 
samples were cooled to 4°C and centrifuged at 2000 
x g for 20 minutes. Following centrifugation, 2 ml 
of the protein free supernatant was removed from 
each tube and 0.5 ml of TBA (0.33%) was added to 
this fraction. All tubes were heated for one hour at 
95°C in a water bath. After cooling, the TBA-MDA 
complexes  were  extracted  with  2  ml  of  butanol. 
vascular endothelial cells, rat myocardium and 
collagen  from  oxidative  damage  (10).  Vajragupta 
et al. showed that three Manganese complexes of 
curcumin exhibited a great capacity to protect brain 
lipids against peroxidation, enhance SOD activity 
and compared to other compound, showed highest 
inhibitory activity against H2O2-induced cell damage 
(12). Therefore, the present study was designed to 
investigate  the  neuroprotective  effect  of  curcumin 
against Hcy toxicity by behavioral studies, as well as 
biochemical analysis to arrive at a conclusion.     
 MATERIAL AND METHODS 
Drugs and Biochemical reagents
D-L-Homocysteine (Hcy), curcumin, butylhldroxy-
toluene  (BHT),  2-thiobarbituric  acid  (TBA), 
1.1.3.3  tetramethoxypropan  (99%),  nitro  blue 
diformazan (NBD), nitro blue tetrazolium (NBT), 
trichloroacetic acid (TCA), butanol and ethyl oleate, 
hematoxylin  &  eosin,  DAB,  xylene,  caspase  3 
antibody,  envision  antibody,  diamino  banzydil, 
hydrogen  peroxide  were  purchased  from  Sigma-
Aldrich and Cell Signaling company, Germany. 
Animals
Adult male Wister rats which were purchased from 
Pasteur institute (Tehran, Iran), and weighing between 
250-300g were used in this study. The animals were 
housed at 22°C in a controlled environment with a 
12:12 hrs light: dark cycle and had access to standard 
laboratory food and water ad libitum. All experiments 
were carried out in accordance with the guide for the 
care and use of laboratory animals (National Institutes of 
Health Publication No. 80-23, revised 1996) and were 
approved by the research and ethics committee of 
the Shahid Beheshti University, M.C.
Drugs- preparation and administration        
Hcy  powder  was  dissolved  in  hydrochloric  acid 
(1 M) and diluted with Phosphate Buffered Saline 
(PBS) (13). The PH of the solution was regulated at 
7.4 by addition of 0.1N NaOH. Solutions of Hcy were 
prepared freshly at concentration of 0.05, 0.1, 0.2 and 
0.4 M. Hcy effective dose (0.2 µmol/µl) was calculated 
by drawing a dose-response diagram (Figure 1). 
The yellow powder of curcumin was dissolved in 
absolute ethanol and stored as stock solution (1%) at 
- 20°C. For injection, it was diluted with ethyl oleate 
(vehicle) and administrated  at low, middle and high 
doses (5, 15 and 45 mg/kg) i.p. in rats. Curcumin 
dosages were selected on the basis of earlier reports, 
which have demonstrated its antioxidant effects (15, 
16).  Six  groups  with  eight  animals  in  each  group 
were employed in this study. Control group did not 
receive any injection.  In the sham group, vehicle of 
Hcy (PBS) was injected (i.c.v) and vehicle of curcumin 
(ethyl oleate) was injected (i.p.) for 10 days beginning 
5 days prior to PBS injection. In the Hcy group, Hcy 
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spectrophotometer and MDA levels were determined 
from standard curve that was generated from 1,1,1,3 
Tetramethoxypropan. The results are represented as 
n moles/mg tissue.
For  detection  of  SOA,  the  assay  procedure  was  a 
modification of the method described by Das et al. 
(19). Brain homogenate (1 ml) was incubated with 0.4 
ml of NBT (0.1%) in an oscillating water bath for one 
hour at 37 °C. Termination of the assay and extraction 
of the reduced NBT was carried out by centrifuging 
the samples for 10 min at 2000 x g, followed by re-
suspension of the pellets with 2 ml of glacial acetic 
acid. The absorbance was measured at 560 nm on a 
spectrophotometer  and  converted  to  micromoles  of 
Diformazan using a standard curve generated from 
NBD. The results are expressed as µ moles/mg tissue.
Hippocampus histopathological analysis
Because of the important role of hippocampus in 
the memory, its  histopathological was investigated. 
So removed rat’s hippocampal tissues were fixed in 
10% neutral buffered formaldehyde for 24 hours, 
embedded  in  paraffin  and  cut  into  3-4  µm  thick 
sections by a microtome (Leica SM2000R, Germany). 
The tissue sections were de-paraffinised in xylene. 
The slides were stained with Hematoxylin and 
Eosin (H&E) according to the procedure of Wilson 
et al. (35) and viewed under a light microscope 
(Labomed, USA) for the structure and morphology 
of cells. Microscopic images obtained by a CCD 
camera and Digipro software. The cells also were 
counted  in  different  regions  of  hippocampus 
(CA1, CA2, CA3 and DG) by the grade of light 
microscope.  The  results  are  represented  as  cell 
count per mm2 tissue. Also some of slides were 
investigated  by  Immunohistochemical  methods.   
In  these  processes,  the  primary  and  secondary 
antibodies were used and Caspase 3 (an apoptotic 
cytoplasmic  protein)  was  detected  as  brown 
color after making complex with DAB (Diamino 
Banzydil). 
Behavioral study
The effects of Hcy alone or in combination with 
curcumin  on  the  rats’  behavior  were  studied  by 
passive avoidance learning task. Locomotor activity 
was also studied by Open field apparatus. All studies 
were  begun  24  hrs  after  the  last  curcumin  or  its 
vehicle injection in the fifth day following Hcy (i.p.) 
injection.
Passive avoidance learning apparatus
The  apparatus  (shuttle  box)  consisted  of  equal 
sized light and dark compartments (30 × 20 × 30 
cm), separated by a guillotine door (7 × 9 cm) that 
could be raised to 10 cm. A 40 W lamp was fixed 
30  cm  above  the  floor  in  the  center  of  the  light 
compartment. The  floor  was  made  from  stainless 
steel (2.5 mm in diameter) and connected to a shock 
stimulator. A single electrical shock (50 Hz, 1.5 sec, 
1.5-2 mA intensity) were delivered to the grid floor 
of the dark compartment by a stimulator.
Training
Five days after Hcy (i.c.v) injection, the rats were 
individually allowed to habituate to the apparatus 
one hour prior to testing. All behavior tests were 
performed at 9:30 – 10:30 AM in a darkened, light 
and  sound  attenuated  and  ventilated  testing  room 
at  20-25°C.  Each  animal  was  placed  in  the  light 
compartment, and after 5 sec, the door was opened, 
and  animals  were  allowed  to  enter  a  dark  place. 
The habituation trial was repeated after 30 minutes 
followed by the acquisition trial after an additional 
30 minutes. Thus, every animal was placed in the 
light compartment and the latency time that elapsed 
before each animal had all four feet inside the dark 
compartment was measured in seconds and termed 
“Initial Latency” time (IL). Immediately after the 
rat entered the dark chamber with all the four feet 
inside, the door was closed and an electrical foot 
shock (1.5-2 mA, 50 Hz, 1.5 sec) was delivered. 
After 20 sec, the rats were removed from the dark 
chamber and returned to their own cages. Rats that 
had an IL time of more than 100 sec were excluded 
from further experiments. Any rat that was excluded 
in initial latency test, replaced with the new rat so the 
number of rats in each groups were kept fixed at 8. 
Two minutes later, the rats were re-tested in the same 
way. If the rats did not enter the dark compartment 
during  120  sec,  successful  acquisition  of  passive 
avoidance response would be recorded (20).
Retention test
Twenty-four  hrs  after  training,  the  retention  test 
was  performed.  Each  rat  was  placed  in  the  light 
compartment for 5 sec, the door was opened and the 
step through latency time was measured and termed 
the “Retention Latency” time (RL); but foot shock 
was not delivered. The test was concluded when the 
animal entered the dark compartment or remained in 
the light site for 600 sec as an upper cut of time (20).
Open field test
The  general  stimulant  or  depression  activity  of 
a  CNS-active  drug  may  affect  the  response  of 
an  animal  on  behavioral  paradigm.  Therefore, 
the  effect  of  curcumin  and  Hcy  on  spontaneous 
locomotor activity in open field were also studied. 
Spontaneous locomotor activities were measured on 
days of 5, 6 after Hcy (i.c.v) injection. In these days 
initial and retention latency times were also measured. 
Each animal was observed over a period of 5 min in 
a square open arena (30 × 30 cm) equipped with 
an infrared light-sensitive photocell using a digital 
photoactometer and recorded by a video path analyzer. 
Measurements  were  expressed  as  locomotion,  rest; 
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Statistical analyses 
The  data  of  behavioral,  biochemical  and 
histopathological studies were analyzed using one-
way analysis of variance (ANOVA). If the F values 
were  significant,  the  student  Newman-  Keuls  test 
was used to compare the experimental and control 
groups. P-values less than 0.05 were considered to 
be statistically significant.
                                                                     
RESULTS
Hcy Dose-Response diagram
Figure  1  shows  Hcy  dose-response  diagram  on 
rat’s whole brain lipid peroxidation, dose- response 
regression line and EC50. It was found that 0.2 µmol/
µl was the maximum safe effective dose of Hcy 
to  induce  lipid  peroxidation. Also  EC50  was  0.1 
µmol/µl. Higher concentration of Hcy (more than 
0.4 µmol/µl) caused side effects, some morbidity 
and mortality in rats.
Estimation of oxidative stress parameters
Figure  2  shows  the  effects  of  drugs  on  lipid 
peroxidation. One-way ANOVA indicated that MDA 
level in Hcy group was increased significantly as 
compared to the sham group [F (5, 42) =164.54, 
p<0.001]. Curcumin treatment (5, 15 and 45 mg/
kg; i.p.) decreased the MDA level significantly 
(p<0.001) and at 45 mg/kg decreased the MDA 
level less than that of 5 mg/kg (p<0. 01).
Figure 3 shows the effects of drugs on superoxide 
anion level (μmol/mg wet tissue) in the rats’ whole 
brain. One-way ANOVA indicated that SOA level 
in Hcy group was significantly greater than that of 
sham group at doses of [F (5, 42) =220.98, p<0.001]. 
Curcumin treatment with 5, 15 and 45 mg/kg led to 
a significant decrease in SOA level (p<0.001) and at 
45 mg/kg decreased the SOA level less than those of 5, 
15 mg/kg doses (p<0. 01).
Estimation of histopathological parameters
One-way ANOVA indicated that the cell density of 
Dentate Gyrus (cell count per mm2) in Hcy group 
(Figure 4a) was significantly (p<0.001) lower than 
that of the sham group (Figure 4b). However, after 
curcumin treatment the cell density was increased 
significantly in comparison with Hcy group at doses 
of 15 and 45 mg/kg (p<0.01). 
Immunohistochemical  study  (Figure  4c)  indicated 
that the cell layer of dentate gyrus in control group 
did  not  show  any  apoptotic  changes.  But  in  Hcy 
group the color of cytoplasm was changed to brown 
indicating the reaction of Caspase 3 with antibody 
and so the possibility of apoptosis may have occurred. 
After curcumin (45 mg/kg) treatment the cytoplasm 
brown color was disappeared. Therefore apoptosis 
was inhibited upon treatment with curcumin.
Estimation of learning and memory parameters
In  this  set  of  experiments,  Panel  a  in  Figure  5   
represents initial latency times that was recorded in 
the training process before electrical shock and these 
times were naturally less than the retention latency 
times (RL) (panel b) that was recorded in retention 
test, 24 hrs after electrical shock. One-way ANOVA 
indicated that initial latency time (IL) did not differ 
between control and experimental groups (Figure 5a) 
while the mean RL times (Figure 5b) in Hcy group 
was  significantly  [F  (5,  42)  =18.50,  p  <0.001] 
less than that in sham group (p<0.001). However, 
curcumin at the doses of 5 mg/kg (p<0.01) and 
15, 45 mg/kg (p<0.001) significantly reversed the 
Hcy-mediated decrease in step through latency time 
and increase in the mean of RL times (p<0.001). 
Locomotor activity
One-way  ANOVA  indicated  that  there  were  not 
any significant differences in locomotor activities 
between  control  and  experimental  groups  on  the 
days of 5, 6 after Hcy (i.c.v.) injection.
DISCUSSION
The  aim  of  this  study  was  to  investigate  and 
clarify  the  neuroprotective  effects  of  curcumin, 
a  polyphenolic  non-enzymatic  antioxidant  agent, 
against Hcy neurotoxicity. The goal was to establish 
an animal model of Hcy- induced oxidative stress in 
the rat’s brain according to previous investigations 
(22-24). The present study indicated that Hcy was 
neurotoxic  for  rats.  Biochemical  results  revealed 
that  five  days  after  Hcy  (i.c.v)  injection,  MDA 
and SOA levels were significantly increased in the 
whole brain tissue in comparison with the sham and 
control groups (Figure 2,3). In the present study, it 
was observed that Hcy overdose can be lethal for rats 
and some morbidity and mortality were observed 
after  administration  of  0.4  μmol/μl  or  higher 
concentrations.  Furthermore,  results  of  this  study 
indicated  that  Hcy  (0.2μmol/μl)  could  impair  the 
memory  significantly,  and  decreased  latency  time 
in the retention test. As it is shown, Hcy group had 
significantly lower latency time than other groups 
(Figure 5). The effects of Hcy on the memory have 
been  investigated  in  some  of  the  earlier  studies. 
It has been found that long-term exposure of Hcy 
induced alteration in spatial learning, hippocampal 
signaling and synaptic plasticity (25).
Streck  et  al.  (26)  revealed  that  chronic  hyper-
homocysteinemia impaired memory in the rat. It was 
suggested that Hcy might generate reactive oxygen 
species (ROS), which attack the poly unsaturated 
fatty acids (PUFA) of neuronal cell membranes and 
induce lipid peroxidation in the rat brain (26). Hcy 
may also modulate intracellular signaling, ultimately 
leading to neuronal death via apoptosis or necrosis 
(27).  ROS  are  highly  reactive  for  all  biological 
macromolecules  (e.g.  proteins,  DNA  and  lipids). 
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Figure 2. Effects of Curcumin (5, 15 and 45 mg/kg) on MDA 
concentration of rats’ brain in Hcy (0.2μmol/μl) treated rats. 
Curcumin at the dose of 45mg/kg decreased MDA concentration 
less  than  5  mg/kg  (p<0.01).  In  the  Control  group  nothing 
were injected, In the Sham group, vehicles of Hcy (i.c.v) and 
Curcumin ( i.p.) were injected. Each point is the Mean ± SEM (n = 
8). ** p<0.01, difference between two doses of curcumin, *** 
p<0.001 difference from Hcy group, +++ p<0.001 difference 
from sham group.
Figure 3. Effects of curcumin (5, 15 and 45 mg/kg) on Super 
oxide anion (Diformazan) concentration of rats’ brain in Hcy (0.2 
μmol/μl) treated rats. Curcumin at the dose of 45mg/kg decreased 
SOA  (Diformazan)  concentration  less  than  5  mg/kg  (p<0.01). 
In the control group nothing was injected, In the Sham group, 
vehicles of  Hcy (i.c.v) and curcumin (i.p.) were injected. Each 
point is the Mean ± SEM (n = 8). ** p<0.01, difference between 
two doses of curcumin, *** p<0.001 difference from Hcy group,
+++ p<0.001 difference from sham group
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neuroprotective effects of Curcumin 132PUFAs are extremely sensitive to free radicals due 
to  their  double  bonds.  ROS  attacks  on  PUFAs, 
initiates a chain reaction called “lipid peroxidation” 
(28). In the course of this process, many detrimental 
metabolites, such as peroxides, aldehydes, ketones 
and  alcoholes  are  generated.  Peroxides  and 
aldehydes,  especially  4-hydroxy-nonenal  (HNE) 
and MDA, are the key-factors for the initiation and 
propagation of atherosclerosis, inflammation, cancer 
and neurodegenerative diseases (29). 
In the present study the loss of dentate gyrus cells 
by  Hcy  was  observed. The  role  of  dentate  gyrus 
of  hippocampus  on  memory  was  investigated  in 
previous  studies.  Kim  et  al,  (22)  investigated  the 
effect of treadmill exercise on memory in relation 
to neurogenesis and apoptosis in the hippocampal 
dentate gyrus of old-aged rats (36). They showed 
that loss of memory by aging was associated with a 
decrease in neurogenesis and an increase in apoptosis 
in the hippocampal dentate gyrus. McHugh et al. 
(37) showed dentate gyrus NMDA receptors mediate 
rapid pattern separation in the hippocampal network 
(37). They tested this hypothesis by generating and 
analyzing a mouse strain that lacks the gene encoding 
the  essential  subunit  of  the  N-methyl-D-aspartate 
(NMDA) receptor NR1, specifically in dentate gyrus 
granule cells. The mutant mice performed normally 
in contextual fear conditioning, but were impaired in 
the ability to distinguish two similar contexts.
Curcumin treatment at low, middle and high doses 
(5, 15 and 45 mg/kg) inhibited lipid peroxidation 
significantly and decreased MDA and SOA levels 
in the Hcy-treated rats’ brain (Figures 2,3). On the 
other hand, the higher dose of curcumin (45 mg/kg) 
decreased  lipid  peroxidation  less  than  that  of 
5  mg/kg  dose  (p<0.01).  Nonetheless,  curcumin 
also improved Hcy-mediated memory deficits and 
increased  latency  times  in  the  passive  avoidance 
tests (Figure 5). According to results, curcumin has 
a dose-related antioxidant effects on the whole brain 
tissue. Curcumin by itself did not affect the learning 
and  memory  but  improved  these  functions  which 
were impaired by Hcy. In a previous study, Pan et al. 
(11) indicated that curcumin improved learning and 
A
a
Hcy group Control group Curcumin 45 mg/kg group
Curcumin 45 mg/kg group Control Hcy
B
b c
Figure 4. A: Photographs were taken from rats’ granular cells 
of  hippocampus  dentate  gyrus  stained  with  Hematoxylin 
and Eosin. B: Immunohistochemical analysis of rat’s granular 
cells of hippocampus dentate gyrus in experimental groups. C: Cell 
density curve from different layers of rats’ hippocampus sections. 
Each point is the mean ±SEM. ** p< difference from Hcy 
group, ++ p<0.001 difference from sham group.
C
  Control   Blank  Vehicle        5             15         45
C
e
l
l
 
d
e
n
s
i
t
y
 
(
C
e
l
l
 
c
o
u
n
t
/
m
m
2
)
 
 
240
160
80
0
Sabetkasaei et al / DARU 2010 18 (2) 128-136 133memory in mice and investigated the neuroprotective 
effect of curcumin on the memory of AD mice in 
the  step-through  test  (11).  Curcumin  reduced  the 
number of step-through errors and prolonged step-
through  latency  in AD  mice  (11).  Curcumin  also 
attenuated  the  neuropathological  changes  in  the 
hippocampus and inhibited apoptosis (11). Lim et 
al. showed that curcumin reduced oxidative damage 
and amyloid pathology in an Alzheimer transgenic 
mouse (30). They also showed that low and high 
doses of curcumin significantly lowered oxidized 
proteins  and  interleukin-1beta,  a  proinflammatory 
cytokine, elevated in the brains of these mice (30). 
Kumar et al. (31) also showed that chronic treatment 
with curcumin (10, 20 and 50 mg/kg; per os) once 
daily for a period of 8 days beginning 4 days prior 
to  3-  Nitropropionic  acid  (3-NP)  administration, 
dose-dependently  improved  the  3-NP-induced 
motor and cognitive impairment (31). Biochemical 
analysis  revealed  that  curcumin  administration 
significantly  attenuated  3-NP-induced  oxidative 
stress  in  the  brains  of  rats  (31). Another  study 
showed that chronic treatment with curcumin (5-50 
mg/kg; per os) twice daily for a period of 25 days 
beginning  4  days  prior  to  colchicines  injection 
significantly  improved  the  Colchicines-induced 
cognitive impairment. Also, chronic administration 
of curcumin significantly reduced the colchicines-
induced elevated lipid peroxidation (32). There are 
multiple biological activities of curcumin (33), such 
as, anti-inflammatory activity via down regulation of 
cyclo-oxygenase 2 and nitric oxide synthase through 
suppression of NF-kappa B activation (34).
Results of this study suggest that the antioxidant 
property  of  curcumin  may  be  responsible  for 
protection against Hcy oxidative stress, possibly 
by  increasing  the  endogenous  defenses  against 
oxidative  stress.  Results  of  this  study  suggest 
that curcumin may scavenge SOA from the whole 
brain tissues. Therefore, curcumin has protective 
effects against lipid peroxidation and decreased 
MDA and SOA formation. Also curcumin at the 
dose of 45mg/kg inhibited cell death (apoptosis) 
in hippocampus.
In conclusion, curcumin could prevent neurotoxicity 
of  Hcy in the rat’s brain. If Hyperhomocysteinemia 
is one of the pathological reasons for neurodegenerative 
disorders such as sporadic AD or Parkinson’s disease, 
curcumin  may  be  an  effective  prophylactic 
agent  in  the  prevention  of  oxidative  stress  by 
Hcy. Furthermore, data of this study suggest that 
curcumin’s mechanism for protection of  the brain 
against  the  toxicity  of  Hcy  may  be  inhibition 
of  brain  lipid  peroxidation  and  improvement  of 
learning and memory deficits in rats. Further studies 
are required to reveal the exact mechanism of Hcy 
in  cell  death  process  (apoptosis  or  necrosis)  and 
the neuroprotective properties of curcumin must be 
studied in more detail.
Figure 6. A- The approximate placements of injection cannulae 
within  the  cerebral  ventricle  are  indicated  by  white  spots. 
Representative sections of the ventricle (- 0.3, - 0.4, - 0.8, -0.92 
mm from bregma) were taken from the rat brain atlas of Paxinos 
and Watson (1998). B- Histological photograph taken from rat’s 
ventricles after methylene blue (i.c.v) injection.
A B
Figure 5. Effects of curcumin (5, 15 and 45 mg/kg) on the passive 
avoidance  behavior  after  Hcy  (0.2  μmol/μl)  i.c.v.  injection  in 
rats. The effects of drugs on (A) Initial latency times (IL) before 
electrical shock in training process (n = 8), (B) Retention Latency 
times (RL), 24 hrs after electrical shock in the retention test (n = 
8). In the Control group nothing was injected, In the Sham group, 
vehicles of Hcy (i.c.v) and Curcumin (i.p.) were injected. Each 
point is the Mean ± SEM (n = 8). *** p<0.001 difference from 
Hcy group, +++ p<0.001 difference from sham group.
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